{"entity":{"id":"nct07045311","kind":"trial","name":"JS207 Combination Therapy in Triple-negative Breast Cancer","aka":[],"tldr":"A phase 2 trial in triple-negative breast cancer, run by Shanghai Junshi Bioscience Co., Ltd., now recruiting.","summary":"JS207 Combination Therapy in Triple-negative Breast Cancer is a phase 2, interventional study registered as NCT07045311 by Shanghai Junshi Bioscience Co., Ltd., with a registry enrolment figure of 80 participants, started 2025-09-17 and due to reach its primary completion in 2028-03-22. Interventions recorded: JS207 in combination with 9MW2821; JS207 in combination with Albumin paclitaxel. Conditions listed: Triple-negative Breast Cancer. Triple-negative eligibility wording from the registry: \"Histologically confirmed unresectable, locally advanced or metastatic triple-negative breast cancer(absence of HER2, ER, and PR expression);\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07045311","url":"https://clinicaltrials.gov/study/NCT07045311"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-early","tnbc-metastatic"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07045311","phase":"2","setting":"JS207 Combination Therapy in Recurrent or Metastatic Triple-negative Breast Cancer(TNBC)","sponsor":"Shanghai Junshi Bioscience Co., Ltd.","enrolled":80,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07045311/","neighbours":{"cancer":[{"id":"tnbc-early","kind":"cancer","name":"Early triple-negative breast cancer","route":"/cancers/tnbc-early/"},{"id":"tnbc-metastatic","kind":"cancer","name":"Metastatic triple-negative breast cancer","route":"/cancers/tnbc-metastatic/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}